Condition : Relapsing Multiple Sclerosis
Interventions : Drug: Evobrutinib; Drug: Placebo (match to Teriflunomide); Drug: Teriflunomide; Drug: Placebo (match to Evobrutinib)
Sponsors : Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany; EMD Serono Research & Development Institute, Inc.
Not yet recruiting
Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)
Wed, 08 Apr 2020 12:00:00 EDT
First Added: 04/08/20 07:22AM